The Hospital for Sick Children and the Michael Smith Genome Sciences Center are conducting a whole-genome sequencing study of 1,000 pediatric brain cancer tumors.

The aim of the study is to find markers that stratify patients for treatment in clinical trials, to identify risk factors that may predispose children to this type of cancer, and to find markers associated with disease prognosis.

The project is being funded with C$9.8 million by Genome BC and other partners and is part of Genome Canada's Large-Scale Applied Research Project Competition.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.